<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-08-29 - In&#xAD;done&#xAD;sian firm plans to sup&#xAD;ply vac&#xAD;cine by end-2021</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20200829/281852940955936" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>In&#xAD;done&#xAD;sian firm plans to sup&#xAD;ply vac&#xAD;cine by end-2021</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20200829/textview" title="The Straits Times - 2020-08-29"><time>2020-08-29</time></a>
        - <span>TOP OF THE NEWS</span>
        - <span role="byline"></span>
    </section>

    <p>• In­done­sia’s big­gest phar­ma­ceu­ti­cal com­pany plans to dis­trib­ute Covid-19 vac­cines by the end of next year as the coun­try grap­ples with one of Asia’s big­gest out­breaks of the dis­ease.</p>
    <p>Kalbe Farma ex­pects to be­gin phase two of clin­i­cal tri­als for a Covid-19 vac­cine in Novem­ber, af­ter its South Korean part­ner, biotech­nol­ogy firm Genex­ine, is set to com­plete phase one tri­als in Oc­to­ber, said pres­i­dent-direc­tor Vid­jongtius, who goes by one name.</p>
    <p>There are faster-mov­ing ef­forts around the world that have reached the fi­nal stages of test­ing their vac­cine’s ef­fi­cacy, while front run­ners in China have sent their shots to hot spots, in­clud­ing In­done­sia, for fi­nal-stage tri­als.</p>
    <p>As su­per­pow­ers like the United States se­cure deals to pro­cure bil­lions of doses, poorer coun­tries from Thai­land to Nige­ria are re­search­ing their own vac­cines amid con­cerns they might fall last in line for the shots.</p>
    <p>In­done­sia’s Health Min­istry an­nounced 3,003 new con­firmed Covid-19 cases yes­ter­day, bring­ing the to­tal num­ber of in­fec­tions na­tion­wide to 165,887.</p>
    <p>The phase two tri­als for the DNA vac­cine called GX-19 may in­volve up to 600 peo­ple in In­done­sia and is set to last un­til next May.</p>
    <p>Kalbe Farma plans to buy the fin­ished prod­uct from Genex­ine to dis­trib­ute lo­cally and may spend one tril­lion ru­piah (S$93 mil­lion) to build a plant with the an­nual ca­pac­ity to pro­duce up to 30 mil­lion doses.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
